Form 4: Inari Medical Director Catherine Szyman Acquires Shares and Receives Restricted Stock Units

Director Catherine M. Szyman of Inari Medical, Inc. reports acquisition of common stock and grant of restricted stock units.

Summary

• Catherine M. Szyman, a director of Inari Medical, Inc., reported a transaction on April 24, 2024.
• Szyman acquired 4,126 shares of common stock at a price of $42.41 per share.
• She also received restricted stock units representing 4,126 shares.
• Following the transaction, Szyman beneficially owns 22,429 shares of Inari Medical, Inc.
• The restricted stock units vest in full on the earlier of the day prior to the Issuer's next annual meeting of stockholders or one year from the date of grant.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock transactions by a company director. The acquisition of shares could be interpreted as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units vest in full on the earlier of (1) the day prior to the Issuer's next annual meeting of stockholders or (2) one year from the date of grant.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's sentiment about the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates